Omnipaque 350 iohexol - visipaque iodixanol
Ended Purchase Order Awarded Last action
- Contract number
- W81K0026PA148
- Awardee
-
PMW Inc. UEI PKY3DHJU6LS3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $289,168
Award facts
- Contract value 100% obligated
- $289,168.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Salt Lake City, UT 84120, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a purchase order to PMW Inc. valued at $289,168.40 on July 1, 2026, for OMNIPAQUE 350 IOHEXOL and VISIPAQUE IODIXANOL contrast media. Performance occurs in Salt Lake City, Utah, with an ultimate completion date of September 30, 2026. The order carries firm fixed pricing and uses no set-aside category.
Quick answers
Who was awarded contract W81K0026PA148?
W81K0026PA148 was awarded to PMW Inc. by Medical Command (Department of the Army) on July 1, 2026.
How much is contract W81K0026PA148 worth?
The government has obligated $289,168 on W81K0026PA148.
Which agency awarded contract W81K0026PA148?
Medical Command (Department of the Army) awarded W81K0026PA148, with funding from Defense Health Agency (Department of Defense).
Was contract W81K0026PA148 competed?
The extent of competition for W81K0026PA148 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award